XML 92 R59.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurement (Details) - Schedule of financial assets and liabilities measured and recognized at fair value - Blade Therapeutics, Inc. [Member] - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Cash and cash equivalents    
Money market funds $ 1,972 $ 1,613
Total financial assets 1,972 1,613
Liabilities:    
Contingent Consideration 7,011 6,432
Convertible Notes at fair value 46,360 23,410
Warrant Liability 3,135 630
Total financial liabilities 56,506 30,472
Fair Value, Inputs, Level 1 [Member]    
Cash and cash equivalents    
Money market funds 1,972 1,613
Total financial assets 1,972 1,613
Liabilities:    
Contingent Consideration
Convertible Notes at fair value
Warrant Liability
Total financial liabilities
Fair Value, Inputs, Level 2 [Member]    
Cash and cash equivalents    
Money market funds
Total financial assets
Liabilities:    
Contingent Consideration
Convertible Notes at fair value
Warrant Liability
Total financial liabilities
Fair Value, Inputs, Level 3 [Member]    
Cash and cash equivalents    
Money market funds
Total financial assets
Liabilities:    
Contingent Consideration 7,011 6,432
Convertible Notes at fair value 46,360 23,410
Warrant Liability 3,135 630
Total financial liabilities $ 56,506 $ 30,472